Tech Company Financing Transactions
MicroPhage Funding Round
Private investors participated in a $6 million funding round for MicroPhage. The round was announced by the company on 10/20/2011.
Transaction Overview
Company Name
Announced On
10/20/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2400 Trade Centre Ave.
Longmont, CO 80503
USA
Longmont, CO 80503
USA
Phone
Website
Email Address
Not Recorded
Overview
MicroPhage's mission is to be a worldwide leader in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Don Mooney
Chief Scientific Officer
Drew Smith
VP - Manufacturing
Preston Brown
VP - Sales
Brian MacDonald
Browse more venture capital transactions:
Prev: 10/19/2011: Booker venture capital transaction
Next: 10/20/2011: Dermira venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs